Viewing StudyNCT00172042



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00172042
Status: COMPLETED
Last Update Posted: 2015-05-04
First Post: 2005-09-13

Brief Title: A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer NSCLC
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Non-Small-Cell Lung Cancer
Keywords:
Name View
Prevention of bone metastases View
Non-Small-Cell Lung Cancer View
Bisphosphonates View
Zoledronic acid View
Bone metastases View